Definitive Contract 75D30119C06541
Award Date
9/30/19
Potential Completion Date
9/29/22
Potential Value
$601K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitized cost-type contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Alabama at Birmingham (UAB) for a study of commercially available diagnostics. The contract has a potential value of $443,826.00 and a completion date of December 31, 2019. UAB is a public research university known for its innovative and interdisciplinary approach to education. The university has experience providing various goods and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $495,559.06 firm fixed price definitive contract to the University of Alabama at Birmingham (UAB) for the project "DETERMINING THE BURDEN OF INVASIVE MOLD INFECTIONS FOLLOWING COVID". The contract has an August 30, 2022 completion date and was awarded on August 31, 2020. UAB is a public research university known for its interdisciplinary approach and has provided various goods and...
This is a definitive contract awarded by the U.S. government to the University of Alabama at Birmingham (UAB), a non-profit educational institution, on December 15, 2002. The contract has a firm fixed price of $1,497,441.00 and a completion date of June 30, 2007. There is no set-aside designation for this contract. UAB has an extensive track record of delivering biomedical and public health research under federal grant awards from agencies like the National Institutes of Health (NIH), Centers...
This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the University of Alabama at Birmingham (UAB) for research and development facilities. The contract has a ceiling value of $51,806,163.19 and a completion date of December 31, 2008. UAB, a public research university and academic medical center, has extensive experience in federal contracting and grants, particularly in areas such as cancer...
This is a $12,630,053.66 definitive, cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human Services to the University of Alabama at Birmingham (UAB) on September 30, 2004. The contract, which has no set-aside designation, is for the "Population Genetics Analysis Program: Immunity to Vaccines/Infections" and has a period of performance through July 31, 2010. As a leading research institution, UAB has a...
This is a definitive federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the University of Alabama at Birmingham (UAB), a non-profit educational institution. The contract, valued at $1,687,776.46, is for other ADP and telecommunications services. The contract does not have a set-aside designation. UAB has a strong track record of securing federal contracts and grants, including work for the Department of Defense, NASA, and the...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) on August 22, 2017. The contract has a potential value of $845,508.52 and a completion date of September 15, 2018. The contract is for in vitro assessment for antimicrobial activity and a comprehensive viral screening panel. This delivery order is...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB), doing business as U A B, for a "COMPREHENSIVE PANEL FOR VIRUSES" contract with a ceiling value of $1,053,577.42. The contract is under the broader In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery Contract (IDC) and has a completion date of September 29, 2016. UAB is a non-profit, public research university...
The University of Alabama at Birmingham (UAB) was awarded a $42,411,498.54 Definitive Contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Extramural Activities (DEA) for biomedical research and services. This is a Cost No Fee contract with an ultimate completion date of December 1, 2013. UAB has a strong track record of securing federal funding for biomedical research, including grants from the National Institutes of Health (NIH). The contract does not...
This federal contract award is an administrative change and deobligation of funding for Contract ID 00266200105D266015439, originally awarded on May 15, 2001 to the University of Alabama at Birmingham (UAB), a public research university. The contract had a ceiling value of $5,990,395.16 and was a Definitive Contract with a Cost No Fee pricing type. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human...